Arvind Zevqethi

Speaking & conversations

Discuss the next commitment before calling the evidence complete

01

What the first stable demonstration did not establish

Forty-minute engineering-leadership discussion · CTOs, product sponsors and equipment-company directors

This proposed session follows a mount geometry from an initial static approval to a repeated-load review in which twelve of forty rigs tilted. Participants examine why the programme held 240 preproduction units, spent ₹62 lakh on redesign and accepted seven additional weeks. The discussion retains Arvind's responsibility for the first approval, rather than begin only with the successful detection. We ask how a conclusion acquires more scope than the test that supports it and how a leader can reopen that conclusion when later evidence changes the decision. The exercise does not prescribe a loading sequence for a real product or claim an educational or clinical outcome. Its purpose is to help sponsors understand the population, configuration and use conditions represented by an engineering statement. Participants leave with questions about what remains untested and who can challenge an approval, without needing to exchange confidential drawings or treat the fictional mechanism as a universal model for equipment development.

02

The six participants inside the passing majority

Forty-five-minute product-evidence workshop · Engineering leaders, education advisers and product teams

The workshop examines a positioning review containing forty-eight right-handed and twenty-four left-handed participants. All in the first group and eighteen in the second met the reviewed criterion, while six left-handed participants did not. Participants consider why the total of sixty-six successes was insufficient for the geometry decision and how the company came to fund ₹84 lakh of adjustable-mount work. We discuss the difference between identifying a limitation, proposing a workaround and demonstrating that a redesigned configuration addresses the relevant condition. The session does not infer clinical skill from positioning or make a small sample prove every user's experience. Its intended contribution is a more careful discussion of who is represented inside a product claim and which further evaluation a changed design needs. The audience can apply those questions to its own review practices while leaving protected participant records and teaching assessments within their proper professional processes.

03

When the slower response matters more than the headline median

Forty-minute controller and programme-sponsor conversation · Technical executives, equipment developers and investment committees

This proposed conversation follows a thirty-six-station teaching-room review with an eighteen-millisecond median and a 110-millisecond 95th percentile. Participants distinguish that result from an isolated eight-millisecond bench observation and examine why the slower tail shaped a ₹96 lakh local-controller programme. A repeated shared-room test recorded a thirty-two-millisecond 95th percentile under stated conditions. We keep the workload, configuration and scope attached to the improvement rather than claim that all delay disappeared or that every classroom would behave identically. The session offers no universal controller architecture or assertion of improved clinical learning. Its purpose is to help leaders connect a performance distribution with the resource decision and the product promise it supports. Participants discuss which questions a central statistic leaves open and how a follow-up review can report progress without making the result broader than the conditions that actually produced it. The group also compares a sponsor-facing summary with the underlying test description to identify where an omitted condition could change the meaning of the proposed product claim.

04

A redesign can be promising while the release remains paused

Thirty-five-minute product-release case discussion · Engineering sponsors, risk leaders and product executives

The session examines a cassette redesign after 1,200 installation attempts produced 1,092 correctly seated and 108 mis-seated results. The company spent ₹58 lakh on a revised latch, then reviewed a separate 200 attempts with 196 correct and four unresolved results. Participants discuss why broader release remained paused despite the encouraging majority and the investment already made. The case distinguishes attempts from distinct participants and avoids treating unequal samples as a controlled proof of universal improvement. It also asks how a sponsor can make the remaining question specific enough for further work without declaring the programme either wholly successful or worthless. The exercise does not prescribe a real device-release decision or infer a clinical outcome from teaching-equipment installation. Its intended value is a clearer leadership account of what the redesign established, what the four unresolved results still require and why expenditure should not determine the conclusion before the evidence is ready.

Short speaker biography

Arvind Zevqethi is a fictional Mangaluru CTO developing dental teaching simulators and practice rigs. His twenty-four-year career connects mechanical design with repeated-use, positioning and controller evidence. The profile retains an owned approval mistake and an unfinished release decision. He holds no statutory seat and does not assess clinical competence or patient outcomes.

Standard speaker biography

Arvind Zevqethi is the fictional CTO of Tevzuni Dental Simulation Works, a Mangaluru manufacturer serving 28 college customers. He leads 38 engineers through four heads with ₹10.2 crore annual engineering expense and a separate ₹3.4 crore approved capital allocation. His twenty-four-year career began in workshop-instrument design before moving into dental teaching equipment. The examples on this site examine a mount approval, user variation, reference-point checks, shared-room response and cassette installation. He has presented engineering matters to directors but holds no statutory appointment. Proposed sessions address the scope of product evidence and the next commitment it can support; they do not assert real engagements or replace educational and clinical assessment by qualified professionals.

Extended speaker biography

Arvind Zevqethi is a fictional Indian CTO based in Mangaluru. He leads engineering at Tevzuni Dental Simulation Works, an invented manufacturer of bench-mounted dental teaching simulators and practice rigs with 185 employees and 28 college customers. His remit comprises 38 engineers through four heads, ₹10.2 crore annual engineering expense and a separate ₹3.4 crore approved capital allocation. Company revenue of ₹58 crore and operating profit of ₹6.1 crore for FY ending March 2026 describe enterprise scale, rather than results attributed solely to engineering. His career began in July 2002 after a mechanical-engineering degree and developed through product design, specialist mechanical leadership and the wider engineering function. Five cases retain an early approval he had to reverse, a handedness-specific positioning limitation, force-display reference checks, a shared-room response tail and unresolved cassette installations after redesign. The engineering results do not establish clinical competence, educational effectiveness or patient-care improvement. He owns 4% of total company equity within the employee owners' 40% and holds no statutory directorship. His fictional IICA registration in June 2026 is accompanied by an unfinished assessment and no exemption. Before accepting either an outside appointment or a speaking invitation, he would examine commercial relationships, preparation needs and the time the commitment requires. All people and engagements are illustrative, showing how a complete technical-leadership narrative can preserve the evidence, cost and limits of a product decision.

An invitation

Contact

I am considering a first outside board contribution in specialist equipment or educational technology, subject to employer consent and a review of my 4% shareholding and commercial relationships. I hold no statutory directorship. The fictional record includes June 2026 IICA registration, an unfinished assessment and no exemption. Twenty-one days is a provisional commitment, not a conclusion about appointment suitability.

Open to
  • Board appointments
  • Advisory roles
  • Speaking invitations

office@arvindzevqethi.example